Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background. Biobanks are vital research infrastructures aiming to collect, process, store, and distribute biological specimens along with associated data in an organized and governed manner. Exploiting diverse datasets produced by the biobanks and the downstream research from various sources and integrating bioinformatics and “omics” data has proven instrumental in advancing research such as cancer research. Biobanks offer different types of biological samples matched with rich datasets comprising clinicopathologic information. As digital pathology and artificial intelligence (AI) have entered the precision medicine arena, biobanks are progressively transitioning from mere biorepositories to integrated computational databanks. Consequently, the application of AI and machine learning on these biobank datasets holds huge potential to profoundly impact cancer research. Methods. In this paper, we explore how AI and machine learning can respond to the digital evolution of biobanks with flexibility, solutions, and effective services. We look at the different data that ranges from specimen-related data, including digital images, patient health records and downstream genetic/genomic data and resulting “Big Data” and the analytic approaches used for analysis. Results. These cutting-edge technologies can address the challenges faced by translational and clinical research, enhancing their capabilities in data management, analysis, and interpretation. By leveraging AI, biobanks can unlock valuable insights from their vast repositories, enabling the identification of novel biomarkers, prediction of treatment responses, and ultimately facilitating the development of personalized cancer therapies. Conclusions. The integration of biobanking with AI has the potential not only to expand the current understanding of cancer biology but also to pave the way for more precise, patient-centric healthcare strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, X., Cruz Rivera, S., Moher, D., Calvert, M. J., Denniston, A. K., The SPIRIT-AI and CONSORT-AI Working Group, SPIRIT-AI and CONSORT-AI Steering Group, Chan, A.-W., Darzi, A., Holmes, C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1034-x · Cited by 1,421
Digital pathology and artificial intelligence
Niazi, M. K. K., Parwani, A. V., & Gurcan, M. N. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30154-8 · Cited by 1,232 · cited 1×
“Such challenges are intrinsic to the process of collecting and analyzing biobank data [13–15].”
BackgroundClinical decision support in the era of artificial intelligence
Shortliffe, E. H., & Sepúlveda, M. J. (2018) · JAMA · doi:10.1001/jama.2018.17163 · Cited by 920
Digital pathology and artificial intelligence in translational medicine and clinical practice
Baxi, V., Edwards, R., Montalto, M., & Saha, S. (2022) · Modern Pathology · doi:10.1038/s41379-021-00919-2 · Cited by 592
Cruz Rivera, S., Liu, X., Chan, A.-W., Denniston, A. K., Calvert, M. J., Ashrafian, H., Beam, A. L., Collins, G. S., Darzi, A., Deeks, J. J., et al. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30219-3 · Cited by 486
Global evolution of research in artificial intelligence in health and medicine: a bibliometric study
Tran, B. X., Vu, G. T., Ha, G. H., Vuong, Q.-H., Ho, M.-T., Vuong, T.-T., La, V.-P., Ho, M.-T., Nghiem, K.-C. P., Nguyen, H. L. T., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030360 · Cited by 472 · cited 1×
“AI refers to computer technologies that simulate human intelligence, including cognitive abilities, deep learning, adaptability, engagement, and sensory comprehension [27,28].”
BackgroundAI for life: Trends in artificial intelligence for biotechnology
Holzinger, A., Keiblinger, K., Holub, P., Zatloukal, K., & Müller, H. (2023) · New Biotechnology · doi:10.1016/j.nbt.2023.02.001 · Cited by 438 · cited 1×
“Additionally, AI and machine learning may be utilized to forecast and comprehend potential adverse events and patient subpopulations more accurately [57].”
BackgroundDigital pathology and computational image analysis in nephropathology
Barisoni, L., Lafata, K. J., Hewitt, S. M., Madabhushi, A., & Balis, U. G. J. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0321-6 · Cited by 264
Cited by
Bekbolatova, M., Mayer, J., Ong, C. W., & Toma, M. (2024) · Healthcare · doi:10.3390/healthcare12020125 · Cited by 404
Future of Artificial Intelligence—Machine Learning Trends in Pathology and Medicine
Hanna, M. G., Pantanowitz, L., Dash, R., Harrison, J. H., Deebajah, M., Pantanowitz, J., & Rashidi, H. H. (2025) · Modern Pathology · doi:10.1016/j.modpat.2025.100705 · Cited by 231
Brancato, V., Esposito, G., Coppola, L., Cavaliere, C., Mirabelli, P., Scapicchio, C., Borgheresi, R., Neri, E., Salvatore, M., & Aiello, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-04891-8 · Cited by 106
“This is directly linked to the potential data management in a digital biobank to allow a complete approach to diseases and also to make these data usable from artificial intelligence (AI) algorithms [14].”
BackgroundAhmed, M. K., Rozario, E., Mohonta, S. C., Ferdousmou, J., Saimon, A. S. M., Moniruzzaman, M., Manik, M. M. T. G., & Hasan, R. (2025) · Journal of Engineering · doi:10.1155/je/9928467 · Cited by 10
Metadata
- Authors
- Frascarelli, C., Bonizzi, G., Musico, C. R., Mane, E., Cassi, C., Guerini Rocco, E., Farina, A., Scarpa, A., Lawlor, R., Reggiani Bonetti, L., Caramaschi, S., Eccher, A., Marletta, S., & Fusco, N.
- Venue
- Journal of Personalized Medicine
- Publisher
- MDPI AG
- Published
- 2023-09-16
- Volume
- 13
- Issue
- 9
- Pages
- 1390
- ISSN
- 2075-4426 (ISSN-L)
- OpenAlex
- W4386814574
- Cited by
- 42
- References
- 8
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.